8-K: Enlightify Notifies NYSE of Plan to Cure Price Deficiency

Enlightify Inc. has informed the New York Stock Exchange of its intent to regain compliance after its stock price fell below the minimum listing requirement.

Summary

• Enlightify Inc. received a notification from the New York Stock Exchange (NYSE) on August 27, 2025, stating that its 30-trading-day average closing price had fallen below $1.00 per share.
• This average price is the minimum required for continued listing on the NYSE under Rule 802.01C of the NYSE Listed Company Manual.
• On September 9, 2025, Enlightify Inc. responded to the NYSE, expressing its intent to cure this share price deficiency and return to compliance.
• The company has a period of six months, subject to possible extension, to regain compliance with the NYSE's continued listing standard and avoid delisting.
• Enlightify's common stock continues to be listed and traded on the NYSE, provided it complies with other listing requirements.
• The NYSE notification does not impact the company's business operations, Securities and Exchange Commission reporting obligations, or any material debt arrangements or other agreements.

Sentiment

Score: 4

Explanation: The delisting notice is a significant negative event, indicating poor stock performance. However, the company's prompt response and stated intent to cure, along with the confirmation that business operations and financial agreements are unaffected, mitigate the immediate severity, suggesting a cautious outlook rather than outright panic.

Positives

• Enlightify Inc. has promptly notified the NYSE of its intent to cure the share price deficiency, indicating a proactive approach to compliance.
• The NYSE notification does not affect the company's business operations, ensuring continuity in its core activities.
• The company's Securities and Exchange Commission reporting obligations remain unchanged, maintaining transparency for investors.
• The notification does not conflict with or cause an event of default under any of the company's material debt arrangements or other agreements, preserving financial stability.

Negatives

• The 30-trading-day average closing price of Enlightify's common stock fell below $1.00 per share, violating NYSE's minimum price requirement.
• The company received a formal notification from the NYSE regarding its non-compliance with continued listing standards, indicating a risk of delisting.
• Failure to regain compliance within the six-month period could lead to the delisting of the company's common stock from the NYSE.

Risks

• Failure to regain compliance with the NYSE's minimum share price requirement within the six-month cure period could result in the delisting of the company's common stock.
• General economic, business, and environmental conditions could adversely affect the company's performance.
• Challenges related to development, shipment, market acceptance, and increased competition from existing and new competitors pose risks.
• Fluctuations in interest rates and currency exchange rates could impact financial results.
• The impact of global outbreaks, such as COVID-19, could affect business operations and financial performance.
• Technological advances and new products introduced by competitors could erode market share.
• Challenges inherent in new product development, including unforeseen difficulties or delays, are present.
• The company's ability to accurately predict future market conditions may be limited.
• Manufacturing difficulties or delays could disrupt production and supply chains.
• Financial instability of economies and sovereign risk in regions where the company operates could impact its business.
• Dependence on the effectiveness of the company's protections for innovative products is a risk.
• Exposure to litigation and/or regulatory actions could result in significant costs and reputational damage.
• Various other factors beyond the company's control could materially affect actual results.

Future Outlook

Enlightify Inc. intends to cure the share price deficiency within six months to regain compliance with NYSE listing standards. The company's actual results may differ materially from forward-looking statements due to various risk factors, including general economic conditions, competition, and market acceptance.

Management Comments

• Enlightify Inc. has notified the New York Stock Exchange of its intent to cure the price deficiency that resulted from its common stock's average closing price falling below $1.00.

Industry Context

Enlightify Inc. operates in two distinct sectors: the production and distribution of humic acid-based compound fertilizers and other agricultural products, and digital asset mining (bitcoins) through its subsidiary Antaeus Tech Inc. The delisting notice is specific to the company's stock performance against NYSE's minimum price rule, rather than a direct reflection of broader industry trends in either agriculture or digital assets, though general economic conditions are cited as a risk factor for the company's overall business.

Comparison to Industry Standards

• The NYSE Rule 802.01C, requiring a minimum 30-trading-day average closing price of $1.00 per share, is a standard continued listing requirement for companies on the New York Stock Exchange. Many publicly traded companies must adhere to similar minimum price thresholds on major exchanges globally to maintain their listing status.

Stakeholder Impact

• Shareholders face the risk of potential delisting if the company fails to regain compliance, which could impact liquidity and valuation of their holdings.
• Employees, customers, suppliers, and creditors are not immediately impacted, as the company stated the notification does not affect business operations or material debt arrangements.

Next Steps

• Enlightify Inc. must work to increase its common stock's average closing price above $1.00 per share for 30 consecutive trading days to regain compliance with NYSE listing standards.
• The company has a six-month period (subject to extension) to achieve this compliance.

Key Dates

Recommendation

The company received a delisting notice from the NYSE due to its stock price falling below $1.00. While this is a significant negative event, the company has promptly notified the NYSE of its intent to cure the deficiency and has a six-month period to regain compliance. The filing explicitly states that this notification does not affect business operations, SEC reporting obligations, or material debt arrangements. Given the proactive response and the absence of immediate operational impact, a 'hold' recommendation is appropriate to observe the company's progress in regaining compliance. A 'sell' would be premature given the cure period, and a 'buy' would be too risky given the current non-compliance.

Keywords

Enlightify Inc., ENFY, NYSE, Delisting, Stock Price, Compliance, Humic Acid, Fertilizers, Agricultural Products, Digital Asset Mining, Bitcoin